WO2001052979A1 - Method for preparing stable and functionalised colloidal particles and resulting particulate reagent - Google Patents
Method for preparing stable and functionalised colloidal particles and resulting particulate reagent Download PDFInfo
- Publication number
- WO2001052979A1 WO2001052979A1 PCT/FR2001/000206 FR0100206W WO0152979A1 WO 2001052979 A1 WO2001052979 A1 WO 2001052979A1 FR 0100206 W FR0100206 W FR 0100206W WO 0152979 A1 WO0152979 A1 WO 0152979A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chosen
- functional groups
- particles
- organic
- copolymers
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0008—Sols of inorganic materials in water
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0021—Preparation of sols containing a solid organic phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0047—Preparation of sols containing a metal oxide
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
- B01J13/16—Interfacial polymerisation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
- C08J3/21—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase
- C08J3/215—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase at least one additive being also premixed with a liquid phase
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
Definitions
- the stability of colloidal particles depends on the interaction of different interparticle attractive and repelling forces.
- the attractive forces are the van der Waals forces and the repulsive forces are either electrostatic or steric in nature.
- the present inventors have now found a process which makes it possible to obtain colloidal particles, stable and functionalized, even in a medium rich in salt, by electrostatic and steric stabilization and which have many functional groups available for the covalent grafting or not of compounds organic.
- a colloidal, stable and isodisperse dispersion of organic and / or inorganic particles in an aqueous medium said particles having functional groups X capable of interacting with other functional groups, said functional groups X being chosen from amine, hydroxyl, thiol, aldehyde, ester, anhydride, acid chloride, carbonate, carbamate, isocyanate and isothiocyanate groups or their mixtures, said dispersion is brought into contact with a solution of a polymer carrying functional groups ionizable, Z and Z ', identical or different, chosen from the amine, carboxylic acid, ester, anhydride, aldehyde, thiol, disulfide, ⁇ -halocarbonyl, sulfonic acid, isocyanate and isothiocyanate groups to constitute a mixture, and said mixture is incubated under conditions predetermined by a person skilled in the art who knows how to adjust the temperature, the pH and the incubation
- the temperature is between 15 and 60 ° C., advantageously between 20 and 35 ° C.
- the incubation time is between 5 minutes and 24 hours, from preferably between 10 minutes and 3 hours
- the pH is between 6.5 and 7.5.
- Table 1 summarizes the complementarities between the different functional groups X, Z and Z '.
- the colloidal dispersion is a dispersion of organic particles consisting of at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethyl
- the dispersion is a dispersion of organic and inorganic particles, said organic particles being constituted by at least one organic polymer chosen from at least one homopolymer or copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular the N -alkylacrylamide and NN-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylamide , N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylst
- polypeptides such as polylysine and polyarginine
- dendrimers in particular, poly (maleic anhydride methyl vinyl ether), poly (N-vinylmorpholine-N-acryloxysuccinimide) or poly (N-vinylpirrolidone-N-acryloxysuccinimide).
- the invention also relates to a particulate reagent having an affinity for biological compounds comprising or consisting of organic and / or inorganic colloidal particles, stable and functionalized, comprising a core and an envelope.
- the core is essentially solid, organic and / or inorganic, and has functional groups X chosen from amine, hydroxyl, thiol, aldehyde, ester, anhydride, acid chloride, carbonate carbamate, isocyanate, isothiocyanate or mixtures thereof, including at least one fraction reacted with other functional groups of the envelope, and the envelope consists of a polymer carrying functional groups, ionizable, Z and Z ', identical or different, chosen from amine, acid groups carboxylic, ester, anhydride, aldehyde, thiol, disulfide, ⁇ -halocarbonyl, sulfonic acid, isocyanate and isothiocyanate, which partially reacted with the functional groups X of the heart.
- biological compound is intended to mean in particular proteins, including holoproteins and heteroproteins or their fragments, that is to say, lipoproteins, glycoproteins, hemoproteins, phosphoproteins, flavoproteins, metalloproteins, polypeptides, antigens, immunogens, antibodies, enzymes.
- proteins and nucleic acids such as complex nucleoprotein structures such as chromosomes, histones, but also viruses, bacteria, fungi.
- nucleic acids and their fragments are oligonucleotides.
- the core is organic and comprises at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from monomers of acrylamide and acrylate, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylm , N-cyclopropylacrylamide, N, N- diethylacrylamide, M-methyl-N-isopropylacrylamide, N-methyl-Nn- propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butyl-
- the core is organic and inorganic and comprises: at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, - ethylstyrene,
- the envelope polymer is chosen from at least one hydrophilic homopolymer or copolymer chosen from homopolymers or copolymers: - resulting from the polymerization of at least one monomer chosen from monomers derived from acrylamide or from methacrylamide; acrylic acid, methacrylic acid; acrylate and methacrylate derivatives; allylamine; styrenic derivatives; on the condition, if it is a homopolymer, that it contains ionizable functional groups; in particular the copolymers or homoplymers of maleic anhydride and the homopolymers or copolymers of acryloxysuccinimide, - polysaccharides, such as chitosan and poly galacturonic acid,
- polypeptides such as polylysine and polyarginine
- polyethyleneimine - linear or branched polyethyleneimine, and - dendrimers; in particular poly (maleic vinyl ether anhydride) poly (N-vinylmorpholine-N-acryloxysuccinimide) or poly (N-vinylpirrolidone-N-acryloxysuccinimide).
- colloidal particles of the invention and in particular the reagent obtained from these particles, are in particular used for:
- grafting of molecules via their available reactive functions in particular the grafting of biological molecules, such as nucleic acids, fragments of nucleic acids, oligonucleotides, peptides, proteins, fragments of proteins (the term peptides, proteins and fragments of proteins including proteins according to their usual definition, ie proteins produced by the expression of a gene, antigens and immunogens, but also antibodies, fragments' d 'antibodies-, enzymes); the grafting of non-biological molecules, such as markers, for example fluorescent, luminescent molecules or radioisotopic markers; drug substances; pigments; mineral fillers,
- the particles of the invention can be used in the fields of analysis, in particular biological or chemical analysis; in methods of extraction or isolation and / or purification and / or concentration of biological or chemical molecules and more specifically in diagnostic tests, methods of extraction, purification and concentration of proteins and nucleic acids, methods of purifying and screening drug substances or compounds for vaccine use and depollution methods.
- the appended figure represents the measurements of electrophoretic mobility carried out on the latex. Before. Modification (represented by a solid line) and on conjugate 2 (represented by a broken line) of Example 4. The pH is presented on the abscissa and the electrophoretic mobility is represented on the ordinate.
- Example 1 Obtaining magnetic carboxylic latexes.
- the poly (maleic methyl vinyl ether anhydride) (AMVE) (Molar mass: 67 kDa) is dissolved in anhydrous dimethyl sulfoxide (DMSO) (2 g / l). 50 ⁇ l of this AMVE solution are diluted in 1 ml of phosphate buffer (pH 6.8; 10 mM) and then incubated for 10 minutes at 37 ° C. Then mixed 1 ml of a dispersion of amino magnetic latex (0.5% in water 1 times the critical micelle concentration (CMC) of Triton X-405) manufactured, for example according to the protocol described in the patent application PCT WO 99/35500, with 125 ⁇ l of the mixture (AMVE-DMSO-buffer) previously prepared. The mixture is incubated at 37 ° C for 3 hours. The particles can then be used as such or after a purification step, for example by magnetization or centrifugation.
- DMSO dimethyl sulfoxide
- Example 2 Grafting of oligonucleotides [H2N- (CH2) 6-dT14)].
- the latex obtained has a solid content of 8.8% and the particle diameter is 358 nm at 20 ° C.
- Example 4 functionalization of the amino latexes by AMVE.
- a solution of AMVE polymer at 1 g / l in anhydrous DMSO is prepared. 250 ⁇ l of this solution are dissolved in 4.75 ml of phosphate buffer (pH 6.8; 10 mM). The whole is incubated for 10 minutes at approximately 37 ° C. At room temperature, 475 ⁇ l of dispersion of the latex prepared according to Example 3 is then added, at 0.5% of solid content. The mixture is incubated for 3 hours at 37 ° C. The dispersion can be used as it is or after a purification step by centrifugation.
- the amount of AMVE can be varied by modifying the test sample of the polymer solution in DMSO, as shown in Table 2 below, which reports the variation in particle size as a function of the amount of polymer. added.
- Example 5 Study of the stability of latex particles.
- the colloidal stability of conjugate 2 and of a nonfunctionalized latex was carried out by following the evolution of the size of the particles as a function of the increase in salinity. An increase in size indicates flocculation of the particles.
- the measurements were carried out on the N4 device (Coultronics). The results are presented in Table 3.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention concerns a method for preparing functionalised stable particles which consists in: (i) providing a colloidal dispersion of organic and/or inorganic particles in an aqueous medium, said particles having functional groups X capable of interacting with other functional groups, said functional groups X being selected among amine, hydroxyl, thiol, aldehyde, ester, anhydride, acid chloride, carbonate, carbamate, isocyanate and isothiocyanate groups or mixtures thereof; (ii) contacting said dispersion with a dissolved polymer bearing functional groups, capable of ionisation, identical or different, selected among amine, carboxylic acid, ester, anhydride, aldehyde, thiol, disulphide, α-halogenocarbonyl, sulphonic acid, isocyanate and isothiocyanate groups to form a mixture; and (iii) incubating said mixture in predetermined conditions of temperature, pH and incubation time, so that at least a fraction of said functional groups X reacts with at least a fraction of the functional groups Z and/or Z' to form covalent bonds. The invention also concerns a particulate reagent having affinity for biological compounds.
Description
PROCEDE DE PREPARATION DE PARTICULES COLLOÏDALES STABLES ET FONCTIONNALISEES ET REACTIF PARTICULAIRE OBTENU PROCESS FOR THE PREPARATION OF STABLE AND FUNCTIONALIZED COLLOIDAL PARTICLES AND OBTAINED PARTICULATE REAGENT
La stabilité des particules colloïdales dépend de l'interaction de différentes forces attractives et répulsives interparticulaires. Les forces attractives sont les forces de van der Waals et les forces répulsives sont de nature soit électrostatique, soit stérique.The stability of colloidal particles depends on the interaction of different interparticle attractive and repelling forces. The attractive forces are the van der Waals forces and the repulsive forces are either electrostatic or steric in nature.
Le rôle des effets électrostatiques dans la stabilité colloïdale a été décrit dans la théorie DLVO (Derjagun-Landau-Verwey-Overbeek). Lorsque les effets électrostatiques sont annulés, par adjonction de sel par exemple, les particules, dont la stabilité était assurée par ces forces répulsives, floculent.The role of electrostatic effects in colloidal stability has been described in the DLVO theory (Derjagun-Landau-Verwey-Overbeek). When the electrostatic effects are canceled, for example by adding salt, the particles, whose stability was ensured by these repulsive forces, flocculate.
Afin de maintenir la stabilité colloïdale dans un milieu riche en sel, il faut que les particules aient une stabilisation stérique (Jayachandran et al., J.M.S. - Pure Appl. Chem. A35(12) 1971-1986, 1998). Dans cet article, les auteurs ont fixé, sur des particules de latex portant des fonctions aminé en surface, des " bras " de polyoxyéthylène. Cette méthode permet d'obtenir des particules stables, par stabilisation stérique, mais les groupements fonctionnels sont consommés par le greffage des bras et il n'est plus possible alors de greffer sur les particules ainsi obtenues 'des molécules, par exemple des molécules biologiques.In order to maintain colloidal stability in a medium rich in salt, the particles must have steric stabilization (Jayachandran et al., J.M.S. - Pure Appl. Chem. A35 (12) 1971-1986, 1998). In this article, the authors have attached "arms" of polyoxyethylene to latex particles carrying amine functions on the surface. This method makes it possible to obtain stable particles, by steric stabilization, but the functional groups are consumed by the grafting of the arms and it is then no longer possible to graft molecules, for example biological molecules, onto the particles thus obtained.
Les présents inventeurs ont maintenant trouvé un procédé qui permet d'obtenir des particules colloïdales, stables et fonctionnalisées, même dans un milieu riche en sel, par stabilisation électrostatique et stérique et qui possèdent de nombreux groupements fonctionnels disponibles pour le greffage covalent ou non de composés biologiques.The present inventors have now found a process which makes it possible to obtain colloidal particles, stable and functionalized, even in a medium rich in salt, by electrostatic and steric stabilization and which have many functional groups available for the covalent grafting or not of compounds organic.
Selon ce procédé, on dispose d'une dispersion colloïdale, stable et isodisperse, de particules organiques et/ou inorganiques dans un milieu aqueux, lesdites particules présentant des groupements fonctionnels X susceptibles d'interagir avec d'autres groupements fonctionnels, lesdits groupements fonctionnels X étant choisis parmi les groupements aminé, hydroxyle, thiol, aldéhyde, ester, anhydride, chlorure d'acide, carbonate, carbamate, isocyanate et isothiocyanate ou leurs mélanges, on met en contact ladite dispersion avec une solution d'un polymère portant des groupements fonctionnels ionisables, Z et Z', identiques ou différents, choisis parmi les groupements aminé, acide carboxylique, ester, anhydride, aldéhyde, thiol, disulfure, α-halogénocarbonyle, acide sulfonique, isocyanate et isothiocyanate
pour constituer un mélange, et on incube ledit mélange dans des conditions prédéterminées par l'homme du métier qui sait ajuster la température, le pH et le temps d'incubation dans les conditions de l'expérience, afin que les groupements Z, Z' réagissent partiellement avec les groupements X du cœur Par réaction partielle des groupements fonctionnels Z, Z' avec X, on comprend que des groupements Z et/ou Z' doivent rester disponibles. En effet, lors de la mise en œuvre de ces particules, par exemple, dans l'immobilisation de composés biologiques, la totalité ou au moins une partie de ces groupements Z et/ou Z libres réagiront par interaction covalente et/ou par interaction électrostatique avec les groupements ioniques des composés biologiques à immobiliser.According to this method, there is a colloidal, stable and isodisperse dispersion of organic and / or inorganic particles in an aqueous medium, said particles having functional groups X capable of interacting with other functional groups, said functional groups X being chosen from amine, hydroxyl, thiol, aldehyde, ester, anhydride, acid chloride, carbonate, carbamate, isocyanate and isothiocyanate groups or their mixtures, said dispersion is brought into contact with a solution of a polymer carrying functional groups ionizable, Z and Z ', identical or different, chosen from the amine, carboxylic acid, ester, anhydride, aldehyde, thiol, disulfide, α-halocarbonyl, sulfonic acid, isocyanate and isothiocyanate groups to constitute a mixture, and said mixture is incubated under conditions predetermined by a person skilled in the art who knows how to adjust the temperature, the pH and the incubation time under the conditions of the experiment, so that the groups Z, Z ′ partially react with the X groups of the heart By partial reaction of the functional groups Z, Z 'with X, it is understood that groups Z and / or Z' must remain available. Indeed, during the implementation of these particles, for example, in the immobilization of biological compounds, all or at least part of these free Z and / or Z groups will react by covalent interaction and / or by electrostatic interaction with the ionic groups of the biological compounds to be immobilized.
Selon une étape préférentielle d'incubation au cours du procédé de préparation des particules, la température est comprise entre 15 et 60° C , avantageusement entre 20 et 35° C, le temps d'incubation est compris entre 5 minutes et 24 heures, de préférence entre 10 minutes et 3 heures, et le pH est compris entre 6,5 et 7,5.According to a preferred incubation step during the process for preparing the particles, the temperature is between 15 and 60 ° C., advantageously between 20 and 35 ° C., the incubation time is between 5 minutes and 24 hours, from preferably between 10 minutes and 3 hours, and the pH is between 6.5 and 7.5.
Le tableau 1 ci dessous résume les complémentarités entre les différents groupements fonctionnels X, Z et Z'.
Table 1 below summarizes the complementarities between the different functional groups X, Z and Z '.
01/5297901/52979
Tableau 1Table 1
Selon un objet de l'invention, la dispersion colloïdale est une dispersion de particules organiques constituées par au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N,N-dialkylacrylamide, tels que le N-isopropylacrylamide, le N- méthylacrylamide, le N-éthylméthacrylamide, le N-n-propylacrylamide, le N-n- propylméthacrylamide, le N-isopropylméthacrylamide, le N- cyclopropylacrylamide, le N,N-diéthylacrylamide, le N-méthyl-N- isopropylacrylamide, le N-méthyl-N-n-propylacrylamide ; les acrylates et les méthacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, l'ethylstyrene, le tertio-butyl- styrène, le chlorométhylstyrène, le vinyltoluène ; leurs dérivés et les copolymères de ces monomères entre eux et/ou avec d'autres comonomères.According to an object of the invention, the colloidal dispersion is a dispersion of organic particles consisting of at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butylstyrene, chloromethylstyrene, vinyltoluene; their derivatives and the copolymers of these monomers with one another and / or with other comonomers.
Selon un autre mode de réalisation du procédé de l'invention, la dispersion est une dispersion de particules organiques et inorganiques,
lesdites particules organiques étant constituées par au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N-N-dialkylacrylamide, tels que le N-isopropylacrylamide, le N- méthylacrylamide, le N-éthylméthacrylamide, le N-n-propylacrylamide, le N-n- propylméthacrylamide, le N-isopropylméthacrylamide, le N- cyclopropylacrylamide, le N,N-diéthylacrylamide, le N-méthyl-N- isopropylacrylamide, le N-méthyl-N-n-propylacrylamide ; les acrylates et les methacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, l'ethylstyrene, le tertio-butyl- styrène, le chlorométhylstyrène ; leurs dérivés et les copolymères de ces monomères entre eux ; et lesdites particules inorganiques étant choisies parmi les particules d'oxydes métalliques, de fer, de titane, de cobalt, de zinc, de cuivre, de manganèse, de nickel ; la magnétite ; l'hématite, les ferrites, telles que les ferrites de manganèse, nickel, manganèse-zinc; les alliages de cobalt, nickel ; les zéolites ; le talc ; les argiles telles que bentonite et kaolin ; l'alumine ;' la silice , le graphite ; le noir de carbone ou autres matériaux inorganiques. Par ailleurs, dans le procédé de l'invention, le polymère d'enveloppe est choisi parmi au moins un homopolymère ou un copolymère choisi parmi les homopolymères ou copolymères :According to another embodiment of the process of the invention, the dispersion is a dispersion of organic and inorganic particles, said organic particles being constituted by at least one organic polymer chosen from at least one homopolymer or copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular the N -alkylacrylamide and NN-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylamide , N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butylstyrene, chloromethylstyrene; their derivatives and the copolymers of these monomers with one another; and said inorganic particles being chosen from particles of metal oxides, iron, titanium, cobalt, zinc, copper, manganese, nickel; magnetite; hematite, ferrites, such as manganese, nickel, manganese-zinc ferrites; cobalt, nickel alloys; zeolites; talc; clays such as bentonite and kaolin; alumina; ' silica, graphite; carbon black or other inorganic materials. Furthermore, in the process of the invention, the envelope polymer is chosen from at least one homopolymer or a copolymer chosen from homopolymers or copolymers:
- issus de la polymérisation d'au moins un monomère choisi parmi les monomères dérivés de l'acrylamide ou de méthacrylamide ; l'acide acrylique, l'acide methacrylique ; les dérivés acrylates et methacrylates ; l'allylamine ; les dérivés styréniques ; à la condition s'il s'agit d'un homopolymère que celui ci comporte des groupements fonctionnels ionisables ; en particulier les copolymères ou homoplymères de l'anhydride maléique et les homopolymères ou copolymères de l'acryloxysuccinimide, - les polysaccharides, tels que le chitosane et le polyacide galacturonique,- resulting from the polymerization of at least one monomer chosen from monomers derived from acrylamide or from methacrylamide; acrylic acid, methacrylic acid; acrylate and methacrylate derivatives; allylamine; styrenic derivatives; on the condition if it is a homopolymer that it contains ionizable functional groups; in particular the copolymers or homoplymers of maleic anhydride and the homopolymers or copolymers of acryloxysuccinimide, - polysaccharides, such as chitosan and polyactactic acid,
- les polypeptides, tels que la polylysine et la polyarginine,- polypeptides, such as polylysine and polyarginine,
- la polyéthylèneimine linéaire ou ramifiée, et- linear or branched polyethyleneimine, and
- les dendrimères ;
en particulier, le poly(anhydride maléique méthyl vinyl éther), le poly(N-vinylmorpholine-N-acryloxysuccinimide) ou le poly(N-vinylpirrolidone-N-acryloxysuccinimide).- dendrimers; in particular, poly (maleic anhydride methyl vinyl ether), poly (N-vinylmorpholine-N-acryloxysuccinimide) or poly (N-vinylpirrolidone-N-acryloxysuccinimide).
L'invention concerne également un réactif particulaire ayant une affinité pour des composés biologiques comprenant ou consistant en des particules colloïdales organiques et/ou inorganiques, stables et fonctionnalisées, comprenant un cœur et une enveloppe. Le cœur est essentiellement solide, organique et/ou inorganique, et présente des groupements fonctionnels X choisis parmi les groupements amine, hydroxyle, thiol, aldéhyde, ester, anhydride, chlorure d'acide, carbonate carbamate, isocyanate, isothiocyanate ou leurs mélanges, dont au moins une fraction a réagi avec d'autres groupements fonctionnels de l'enveloppe, et l'enveloppe est constituée d'un polymère portant des groupements fonctionnels, ionisables, Z et Z', identiques ou différents, choisis parmi les groupements amine, acide carboxylique, ester, anhydride, aldéhyde, thiol, disulfure, α-halogénocarbonyle, acide sulfonique, isocyanate et isothiocyanate, qui ont réagi partiellement avec les groupements fonctionnels X du cœur.The invention also relates to a particulate reagent having an affinity for biological compounds comprising or consisting of organic and / or inorganic colloidal particles, stable and functionalized, comprising a core and an envelope. The core is essentially solid, organic and / or inorganic, and has functional groups X chosen from amine, hydroxyl, thiol, aldehyde, ester, anhydride, acid chloride, carbonate carbamate, isocyanate, isothiocyanate or mixtures thereof, including at least one fraction reacted with other functional groups of the envelope, and the envelope consists of a polymer carrying functional groups, ionizable, Z and Z ', identical or different, chosen from amine, acid groups carboxylic, ester, anhydride, aldehyde, thiol, disulfide, α-halocarbonyl, sulfonic acid, isocyanate and isothiocyanate, which partially reacted with the functional groups X of the heart.
Par composé biologique, on entend notamment des protéines, parmi lesquelles on inclut les holoprotéines et les hétéroprotéines ou leurs fragments, c'est à dire, les lipoprotéines, les glycoproteines, les hémoprotéines, les phosphoprotéines, les flavoprotéines, les métalloprotéines, les polypeptides, les antigènes, les immunogènes, les anticorps, les enzymes. On comprend aussi les associations de protéines et d'acides nucléiques telles que des structures complexes nucléoprotéiques comme les chromosomes, les histones, mais aussi les virus, les bactéries, les champignons. Sont également compris dans les composés biologiques, les acides nucléiques et leurs fragments, les oligonucléotides.The term “biological compound” is intended to mean in particular proteins, including holoproteins and heteroproteins or their fragments, that is to say, lipoproteins, glycoproteins, hemoproteins, phosphoproteins, flavoproteins, metalloproteins, polypeptides, antigens, immunogens, antibodies, enzymes. We also understand the associations of proteins and nucleic acids such as complex nucleoprotein structures such as chromosomes, histones, but also viruses, bacteria, fungi. Also included in biological compounds, nucleic acids and their fragments, are oligonucleotides.
Dans un mode de réalisation de l'invention, le cœur est organique et comprend au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N,N-dialkylacrylamide, tels que le N-isopropylacrylamide, le N-méthylacrylamide, le N- éthylméthacrylamide, le N-n-propylacrylamide, le N-n-propylméthacrylamide, le N-isopropylméthacrylamide, le N-cyclopropylacrylamide, le N,N- diéthylacrylamide, le M-méthyl-N-isopropylacrylamide, le N-méthyl-N-n-
propylacrylamide ; les acrylates et les methacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, l'ethylstyrene, le tertio-butyl-styrène, le chlorométhylstyrène vinyltoluène ; leurs dérivés et les copolymères de ces monomères ente eux et/ou avec d'autres comonomères.In one embodiment of the invention, the core is organic and comprises at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from monomers of acrylamide and acrylate, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylm , N-cyclopropylacrylamide, N, N- diethylacrylamide, M-methyl-N-isopropylacrylamide, N-methyl-Nn- propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butyl-styrene, chloromethylstyrene vinyltoluene; their derivatives and the copolymers of these monomers ente them and / or with other comonomers.
Dans un autre mode de réalisation de l'invention, le cœur est organique et inorganique et comprend : au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N,N-dialkylacrylamide, tels que le N-isopropylacrylamide, le N-méthylacrylamide, le N- éthylméthacrylamide, le N-n-propylacrylamide, le N-n-propylméthacrylamide, le N-isopropylméthacrylamide, le N-cyclopropylacrylamide, le N,N- diethylacrylamide, le N-méthyl-N-isopropylacrylamide, le N-méthyl-N-n- propylacrylamide ; les acrylates et les methacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, - l'ethylstyrene, le tertio-butyl-styrène, le chlorométhylstyrène vinyltoluène ; leurs dérivés et les copolymères de ces monomères ente eux et/ou avec d'autres comonomères ; et des particules inorganiques choisies parmi les particules d'oxydes métalliques, de fer, de titane, de cobalt, de zinc, de cuivre, de manganèse, de nickel ; la magnétite ; l'hématite, les ferrites, telles que les ferrites de manganèse, nickel, manganèse-zinc; les alliages de cobalt, nickel ; les zéolites ; le talc ; les argiles telles que bentonite et kaolin ; l'alumine ; la silice ; le graphite ; le noir de carbone ou autres matériaux inorganiquesIn another embodiment of the invention, the core is organic and inorganic and comprises: at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, - ethylstyrene, tert-butyl-styrene, chloromethylstyrene vinyltoluene; their derivatives and the copolymers of these monomers ente them and / or with other comonomers; and inorganic particles chosen from particles of metal oxides, iron, titanium, cobalt, zinc, copper, manganese, nickel; magnetite; hematite, ferrites, such as manganese, nickel, manganese-zinc ferrites; cobalt, nickel alloys; zeolites; talc; clays such as bentonite and kaolin; alumina; silica; graphite; carbon black or other inorganic materials
Le polymère de l'enveloppe est choisi parmi au moins un homopolymère ou copolymère hydrophile choisi parmi les homopolymères ou copolymères : - issus de la polymérisation d'au moins un monomère choisi parmi les monomères dérivés de l'acrylamide ou de méthacrylamide ; l'acide acrylique, l'acide methacrylique ; les dérivés acrylates et methacrylates ; l'allylamine ; les dérivés styréniques ; à la condition, s'il s'agit d'un homopolymère, que celui ci comporte des groupements fonctionnels ionisables ; en particulier les copolymères ou homoplymères de l'anhydride maléique et les homopolymères ou-copolymères de l'acryloxysuccinimide,
- les polysaccharides, tels que le chitosane et le polyacide galacturonique,The envelope polymer is chosen from at least one hydrophilic homopolymer or copolymer chosen from homopolymers or copolymers: - resulting from the polymerization of at least one monomer chosen from monomers derived from acrylamide or from methacrylamide; acrylic acid, methacrylic acid; acrylate and methacrylate derivatives; allylamine; styrenic derivatives; on the condition, if it is a homopolymer, that it contains ionizable functional groups; in particular the copolymers or homoplymers of maleic anhydride and the homopolymers or copolymers of acryloxysuccinimide, - polysaccharides, such as chitosan and poly galacturonic acid,
- les polypeptides, tels que la polylysine et la polyarginine,- polypeptides, such as polylysine and polyarginine,
- la polyéthylèneimine linéaire ou ramifiée, et - les dendrimères ; en particulier le poly(anhydride maléique vinyl éther) le poly(N-vinylmorpholine- N-acryloxysuccinimide) ou le poly(N-vinylpirrolidone-N-acryloxysuccinimide).- linear or branched polyethyleneimine, and - dendrimers; in particular poly (maleic vinyl ether anhydride) poly (N-vinylmorpholine-N-acryloxysuccinimide) or poly (N-vinylpirrolidone-N-acryloxysuccinimide).
Les particules colloïdales de l'invention, et en particulier le réactif obtenu à partir de ces particules, sont notamment utilisés pour :The colloidal particles of the invention, and in particular the reagent obtained from these particles, are in particular used for:
(i) le greffage de molécules par l'intermédiaire de leurs fonctions réactives disponibles, en particulier le greffage de molécules biologiques, telles que des acides nucléiques, des fragments d'acides nucléiques, des oligonucléotides, des peptides, des protéines, des fragments de protéines (le terme peptides, protéines et fragments de protéines incluant les protéines selon leur définition usuelle, c'est à dire les protéines produits de l'expression d'un gène, les antigènes et les immunogènes, mais aussi les anticorps, fragments ' d'anticorps-, les enzymes) ; le greffage de molécules non biologiques, telles que des marqueurs, par exemple dés molécules fluorescentes, luminescentes ou des marqueurs radioisotopiques ; des substances médicamenteuses ; des pigments ; des charges minérales,(i) grafting of molecules via their available reactive functions, in particular the grafting of biological molecules, such as nucleic acids, fragments of nucleic acids, oligonucleotides, peptides, proteins, fragments of proteins (the term peptides, proteins and fragments of proteins including proteins according to their usual definition, ie proteins produced by the expression of a gene, antigens and immunogens, but also antibodies, fragments' d 'antibodies-, enzymes); the grafting of non-biological molecules, such as markers, for example fluorescent, luminescent molecules or radioisotopic markers; drug substances; pigments; mineral fillers,
(ii) la complexation de produits non organiques, en particulier de métaux, tels que les métaux lourds dans des effluents,(ii) the complexation of inorganic products, in particular of metals, such as heavy metals in effluents,
(iii) la floculation assistée, (iv) la récupération assistée d'hydrocarbures, en particulier d'hydrocarbures lourds.(iii) assisted flocculation, (iv) enhanced recovery of hydrocarbons, in particular heavy hydrocarbons.
Ainsi, les particules de l'invention sont utilisables dans les domaines de l'analyse, en particulier l'analyse biologique ou chimique ; dans des procédés d'extraction ou d'isolement et/ou de purification et/ou de concentration de molécules biologiques ou chimiques et plus précisément dans des essais de diagnostic, des procédés d'extraction, de purification et de concentration de protéines et d'acides nucléiques, des procédés de purification et de criblage de substances médicamenteuses ou de composés à usage vaccinal et des procédés de dépollution. La figure annexée représente les mesures de mobilité électrqphorétique effectuées sur le latex .avant .modification (représentée par
un trait plein) et sur le conjugué 2 (représentée par un trait en discontinu) de l'exemple 4. Le pH est présenté en abscisse et la mobilité électrophorétique est représentée en ordonnée.Thus, the particles of the invention can be used in the fields of analysis, in particular biological or chemical analysis; in methods of extraction or isolation and / or purification and / or concentration of biological or chemical molecules and more specifically in diagnostic tests, methods of extraction, purification and concentration of proteins and nucleic acids, methods of purifying and screening drug substances or compounds for vaccine use and depollution methods. The appended figure represents the measurements of electrophoretic mobility carried out on the latex. Before. Modification (represented by a solid line) and on conjugate 2 (represented by a broken line) of Example 4. The pH is presented on the abscissa and the electrophoretic mobility is represented on the ordinate.
Exemple 1 : Obtention de latex magnétiques carboxyliques.Example 1: Obtaining magnetic carboxylic latexes.
Le polymère poly(anhydhde maléique méthyl vinyl éther) (AMVE) (Masse Molaire : 67 kDa) est solubilisé dans du diméthylsulfoxyde (DMSO) anhydre (2g/l). 50 μl de cette solution d'AMVE sont dilués dans 1 ml de tampon phosphate (pH 6,8; 10 mM) puis incubés 10 minutes à 37°C. On mélange ensuite 1 ml d'une dispersion de latex magnétiques aminé (0,5% dans l'eau 1 fois la concentration micellaire critique (CMC) du Triton X-405) fabriqué, par exemple selon le protocole décrit dans la demande de brevet PCT WO 99/35500, avec 125 μl du mélange (AMVE-DMSO-tampon) préalablement préparé. Le mélange est incubé à 37°C pendant 3 heures. Les particules peuvent ensuite être utlisées telles quelles ou après une étape de purification, par exemple par aimantation ou centrifugation.The poly (maleic methyl vinyl ether anhydride) (AMVE) (Molar mass: 67 kDa) is dissolved in anhydrous dimethyl sulfoxide (DMSO) (2 g / l). 50 μl of this AMVE solution are diluted in 1 ml of phosphate buffer (pH 6.8; 10 mM) and then incubated for 10 minutes at 37 ° C. Then mixed 1 ml of a dispersion of amino magnetic latex (0.5% in water 1 times the critical micelle concentration (CMC) of Triton X-405) manufactured, for example according to the protocol described in the patent application PCT WO 99/35500, with 125 μl of the mixture (AMVE-DMSO-buffer) previously prepared. The mixture is incubated at 37 ° C for 3 hours. The particles can then be used as such or after a purification step, for example by magnetization or centrifugation.
Exemple 2: Greffage d'oligonucléotides [H2N-(CH2)6-dT14)].Example 2: Grafting of oligonucleotides [H2N- (CH2) 6-dT14)].
Une quantité de 0,14 mg de latex magnétique modifié par greffage0.14 mg of magnetic latex modified by grafting
12 d'AMVE (dans le tampon phosphate 10 mM, pH 6,8) est mélange avec 10 copies d'oligonucléotides [H2N-(CH2)6-dT14)] contenus dans de l'eau milliQ, 200 μg d'un agent d'activation, l'hydrochlorure de N-éthyl carbodiimide (EDC) en présence de 0,07% de Triton X-405. Le couplage est réalisé en " batch ", tous les réactifs étant mélangés en même temps, pendant 2 heures, à 37°C. Les excès de réactif sont éliminés par des lavages successifs avec le tampon phosphate 10 mM, pH 6,8.12 of AMVE (in 10 mM phosphate buffer, pH 6.8) is mixed with 10 copies of oligonucleotides [H2N- (CH2) 6-dT14)] contained in milliQ water, 200 μg of an agent activation, N-ethyl carbodiimide hydrochloride (EDC) in the presence of 0.07% Triton X-405. The coupling is carried out in "batch", all the reagents being mixed at the same time, for 2 hours, at 37 ° C. Excess reagent is removed by successive washes with 10 mM phosphate buffer, pH 6.8.
La présence des oligonucléotides est révélée par la technique ELOSA " Enzyme-Linked Oligosorbent Assay " (Katz JB et al., Am. J. Vet. Res. 1993 Dec ; 54 (12) : 2021-6 et François Mallet et al., Journal of Clinical Microbiology, June 1993, p1444-1449)).The presence of the oligonucleotides is revealed by the ELOSA "Enzyme-Linked Oligosorbent Assay" technique (Katz JB et al., Am. J. Vet. Res. 1993 Dec; 54 (12): 2021-6 and François Mallet et al., Journal of Clinical Microbiology, June 1993, p1444-1449)).
Exemple 3: Synthèse de particules aminées.Example 3: Synthesis of amino particles.
A une quantité de 49 grammes d'eau déionisée et dégazée sous azote, on ajoute 4,5 grammes de styrène et 0,5 gramme de N-isopropylamide (NIPAM) (commercialisé par la société Kodak). Le mélange est porté à 70°C, puis l'on ajoute 0,05 gramme d'hydrochlorure de 2,2'
azobis(2 amidinopropane) (Wako). On laisse la réaction de polymérisation radicalaire se dérouler pendant 4 heures. On ajoute ensuite un mélange constitué de 0,5 gramme de NIPAM, de 0,055 gramme d'hydrochlorure de l'aminopropyl méthacrylamide (Kodak), de 0,017 g de N,N' méthylènebisacrylamide (Aldrich) contenus dans 5ml d'eau. On additionne ensuite au milieu réactionnel une solution de 0,025 gramme de 2, 2' azobis(2 amidinopropane) (Wako) dans 1 ml d'eau. On laisse la réaction se dérouler pendant 18 heures.To an amount of 49 grams of deionized and degassed water under nitrogen, 4.5 grams of styrene and 0.5 grams of N-isopropylamide (NIPAM) (sold by the company Kodak) are added. The mixture is brought to 70 ° C., then 0.05 gram of 2.2 'hydrochloride is added. azobis (2 amidinopropane) (Wako). The radical polymerization reaction is allowed to proceed for 4 hours. A mixture consisting of 0.5 grams of NIPAM, 0.055 grams of aminopropyl methacrylamide hydrochloride (Kodak), 0.017 g of N, N 'methylenebisacrylamide (Aldrich) contained in 5 ml of water is then added. Then added to the reaction medium a solution of 0.025 gram of 2,2 'azobis (2 amidinopropane) (Wako) in 1 ml of water. The reaction is allowed to proceed for 18 hours.
Le latex obtenu a un taux de solide de 8,8 % et le diamètre des particules est de 358 nm à 20°C.The latex obtained has a solid content of 8.8% and the particle diameter is 358 nm at 20 ° C.
Exemple 4: fonctionnalisation des latex aminés par l'AMVE.Example 4: functionalization of the amino latexes by AMVE.
Une solution de polymère AMVE à 1 g/l dans du DMSO anhydre est préparée. 250 μl de cette solution sont dissous dans 4,75 ml de tampon phosphate (pH 6,8; 10 mM). Le tout est incubé pendant 10 minutes à environ 37°C. A température ambiante, on ajoute ensuite 475 μl de dispersion du latex préparé selon l'exemple 3, à 0,5 % de taux de solide. Le mélange est incubé pendant 3 heures à 37°C. La dispersion peut être utilisée telle quelle ou après une étape de purification .par centrifugation.A solution of AMVE polymer at 1 g / l in anhydrous DMSO is prepared. 250 μl of this solution are dissolved in 4.75 ml of phosphate buffer (pH 6.8; 10 mM). The whole is incubated for 10 minutes at approximately 37 ° C. At room temperature, 475 μl of dispersion of the latex prepared according to Example 3 is then added, at 0.5% of solid content. The mixture is incubated for 3 hours at 37 ° C. The dispersion can be used as it is or after a purification step by centrifugation.
La quantité d'AMVE peut être variée par modification de la prise d'essai de la solution de polymère dans le DMSO, comme le montre le tableau 2 ci dessous, qui rapporte la variation de la taille des particules en fonction de la quantité de polymère ajoutée.The amount of AMVE can be varied by modifying the test sample of the polymer solution in DMSO, as shown in Table 2 below, which reports the variation in particle size as a function of the amount of polymer. added.
Tableau 2Table 2
# : signifie le diamètre des particules à 20°C et à 0,001 M NaCI.
10#: means the particle diameter at 20 ° C and 0.001 M NaCI. 10
Il faut noter que ni le DMSO, ni le polymère dont toutes les fonctions anhydride ont été hydrolysées avant mise en contact avec les particules ne provoquent de variation du diamètre des particules.It should be noted that neither the DMSO nor the polymer, all of the anhydride functions of which have been hydrolysed before being brought into contact with the particles, cause the particle diameter to vary.
Les mesures de mobilité électrophorétique effectuées sur le latex avant modification et sur le conjugué 2, représentées à la figure annexée, montrent que le latex sur lequel le polymère a réagi présente une inversion de charge, ce qui démontre la présence de l'AMVE en surface des particules.The electrophoretic mobility measurements carried out on the latex before modification and on conjugate 2, shown in the appended figure, show that the latex on which the polymer has reacted has a charge reversal, which demonstrates the presence of AMVE on the surface particles.
Exemple 5: Etude de la stabilité des particules de latex.Example 5: Study of the stability of latex particles.
La stabilité colloïdale du conjugué 2 et d'un latex non fonctionnalisé a été menée en suivant l'évolution de la taille des particules en fonction de l'accroissement de la salinité. Une augmentation de la taille traduit une floculation des particules. Les mesures ont été effectuées sur l'appareil N4 (Coultronics). Les résultats sont présentés dans le tableau 3.The colloidal stability of conjugate 2 and of a nonfunctionalized latex was carried out by following the evolution of the size of the particles as a function of the increase in salinity. An increase in size indicates flocculation of the particles. The measurements were carried out on the N4 device (Coultronics). The results are presented in Table 3.
Tableau 3Table 3
Aucune floculation n'est constatée avec le conjugué 2 ayant fixé le polymère AMVE alors que le latex porteur de fonctions amine et stabilisé de façon électrostatique principalement a commencé à floculer.
No flocculation is observed with the conjugate 2 which has fixed the AMVE polymer while the latex carrying amine functions and mainly electrostatically stabilized has started to flocculate.
Claims
1. Procédé de préparation de particules colloïdales stables fonctionnalisées selon lequel, - on dispose d'une dispersion colloïdale, stable et isodisperse, de particules organiques et/ou inorganiques dans un milieu aqueux, lesdites particules présentant des groupements fonctionnels X susceptibles d'interagir avec d'autres groupements fonctionnels, lesdits groupements fonctionnels X étant choisis parmi les groupements amine, hydroxyle, thiol, aldéhyde, ester, anhydride, chlorure d'acide, carbonate et carbamate, isocyanate, isothiocyanate ou leurs mélanges,1. Process for the preparation of functionalized stable colloidal particles according to which, - a colloidal, stable and isodisperse dispersion is available, of organic and / or inorganic particles in an aqueous medium, said particles having functional groups X capable of interacting with other functional groups, said functional groups X being chosen from amine, hydroxyl, thiol, aldehyde, ester, anhydride, acid chloride, carbonate and carbamate, isocyanate, isothiocyanate groups or mixtures thereof,
- on met en contact ladite dispersion avec une solution d'un polymère portant des groupements fonctionnels, ionisables, Z et Z', identiques ou différents, choisis parmi les groupements amine, acide carboxylique, ester, anhydride, aldéhyde, thiol, disulfure, α-halogénocarbonyle, acide sulfonique, isocyanate, isothiocyanate pour constituer un mélange, et- said dispersion is brought into contact with a solution of a polymer carrying functional groups, ionizable, Z and Z ′, identical or different, chosen from amine, carboxylic acid, ester, anhydride, aldehyde, thiol, disulfide, α groups -halocarbonyl, sulfonic acid, isocyanate, isothiocyanate to form a mixture, and
- on incube ledit mélange dans des conditions prédéterminées de température, de pH et de temps d'incubation, de telle , sorte que les groupements fonctionnels Z et/ou , Z' réagissent partiellement avec les groupements fonctionnels X,' pour la formation de liaisons covalentes.- Said mixture is incubated under predetermined conditions of temperature, pH and incubation time, so that the functional groups Z and / or, Z 'partially react with the functional groups X,' for the formation of bonds covalent.
2. Procédé selon la revendication 1 , caractérisé en ce que la température est comprise entre 15 et 60° C , de préférence entre 20 et 35° C, le temps d'incubation est compris entre 5 minutes et 24 heures, de préférence entre 10 minutes et 3 heures, et le pH est compris entre 6,5 et 7,5. 2. Method according to claim 1, characterized in that the temperature is between 15 and 60 ° C, preferably between 20 and 35 ° C, the incubation time is between 5 minutes and 24 hours, preferably between 10 minutes and 3 hours, and the pH is between 6.5 and 7.5.
3. Procédé selon les revendications 1 et 2, caractérisé en ce que la dispersion est une dispersion de particules organiques, lesdites particules étant constituées par au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N-N- dialkylacrylamide, tels que le N-isopropylacrylamide, le N-méthylacrylamide, le N-éthylméthacrylamide, le N-n-propylacrylamide, le N-n-propylméthacrylamide, le N-isopropylméthacrylamide, le N-cyclopropylacrylamide, le N,N- diéthylacrylamide, le N-méthyl-N-isopropylacrylamide, le N-méthyl-N-n- propylacrylamide ; les acrylates et les methacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, l'ethylstyrene, le tertio-butyl-styrène, le chlorométhylstyrène, le vinyltoluène ; leurs dérivés et les copolymères de ces monomères entre eux.3. Method according to claims 1 and 2, characterized in that the dispersion is a dispersion of organic particles, said particles being constituted by at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization at least one monomer chosen from acrylamide and acrylate monomers, in particular N-alkylacrylamide and NN-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide , Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butyl-styrene, chloromethylstyrene, vinyltoluene; their derivatives and the copolymers of these monomers with one another.
4. Procédé selon les revendications 1 et 2, caractérisé en ce que la dispersion est une dispersion de particules organiques et inorganiques, lesdites particules organiques étant constituées par au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N-N-dialkylacrylamide, tels que le N-isopropylacrylamide, le N- méthylacrylamide, le N-éthylméthacrylamide, le N-n-propylacrylamide, le N-n- propylméthacrylamide, le N-isopropylméthacrylamide, le N- cyclopropylacrylamide, le N,N-diéthylacrylamide, le N-méthyl-N- isopropylacrylamide, le N-méthyl-N-n-propylacrylamide ; les acrylates et les methacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, l'ethylstyrene, le tertio-butyl- styrène, le chlorométhylstyrène ; leurs dérivés et les copolymères de ces monomères entre eux ; et lesdites particules inorganiques étant choisies parmi les particules d'oxydes métalliques, de fer,, de titane, de cobalt, de zinc, de cuivre, de manganèse, de nickel ; la magnétite ; l'hématite, les ferrites, telles que les ferrites de manganèse, nickel, manganèse-zinc; les alliages de cobalt, nickel ; les zéolites ; le talc ; les argiles telles que bentonite et kaolin ; l'alumine ; la silice ; le graphite ; le noir de carbone ou autres matériaux inorganiques.4. Method according to claims 1 and 2, characterized in that the dispersion is a dispersion of organic and inorganic particles, said organic particles being constituted by at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, derived of the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular N-alkylacrylamide and NN-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butylstyrene, chloromethylstyrene; their derivatives and the copolymers of these monomers with one another; and said inorganic particles being chosen from particles of metal oxides, iron, titanium, cobalt, zinc, copper, manganese, nickel; magnetite; hematite, ferrites, such as manganese, nickel, manganese-zinc ferrites; cobalt, nickel alloys; zeolites; talc; clays such as bentonite and kaolin; alumina; silica; graphite; carbon black or other inorganic materials.
5. Procédé selon les revendications 1 , 2, 3 et 4, caractérisé en ce que le polymère d'enveloppe est choisi parmi au moins un homopolymère ou un copolymère hydrophile choisi parmi les homopolymère ou copolymères :5. Method according to claims 1, 2, 3 and 4, characterized in that the envelope polymer is chosen from at least one homopolymer or a hydrophilic copolymer chosen from homopolymers or copolymers:
- issus de la polymérisation d'au moins un monomère choisi parmi les monomères dérivés de l'acrylamide ou de méthacrylamide ; l'acide acrylique, l'acide methacrylique ; les dérivés acrylates et methacrylates ; l'allylamine ; les dérivés styreniques ; à la condition, s'il s'agit d'un homopolymère, que celui ci comporte des groupements fonctionnels ionisables ; en particulier les copolymères ou homoplymères de l'anhydride maléique et les homopolymères ou copolymères de l'acryloxysuccinimide,- resulting from the polymerization of at least one monomer chosen from monomers derived from acrylamide or from methacrylamide; acrylic acid, methacrylic acid; acrylate and methacrylate derivatives; allylamine; styrenic derivatives; on the condition, if it is a homopolymer, that it contains ionizable functional groups; in particular the copolymers or homoplymers of maleic anhydride and the homopolymers or copolymers of acryloxysuccinimide,
- les polysaccharides, tels que le chitosane et le polyacide galacturonique,- polysaccharides, such as chitosan and poly galacturonic acid,
- les polypeptides, tels que la polylysine et la polyarginine, - la polyéthylèneimine linéaire ou ramifiée, et- polypeptides, such as polylysine and polyarginine, - linear or branched polyethyleneimine, and
- les dendrimères.- the dendrimers.
6. Procédé selon la revendication 5, caractérisé en ce que le polymère d'enveloppe est le poly(anhydride maléique méthyl vinyl éther), le poly(N-vinylmorpholine-N-acryloxysuccinimide) ou le poly(N-vinylpyrrolidone- N-acryloxysuccinimide).6. Method according to claim 5, characterized in that the envelope polymer is poly (maleic anhydride methyl vinyl ether), poly (N-vinylmorpholine-N-acryloxysuccinimide) or poly (N-vinylpyrrolidone- N-acryloxysuccinimide ).
7. Réactif particulaire, ayant une affinité pour des composés biologiques, comprenant ou consistant en des articules colloïdales organiques et/ou inorganiques, stables et fonctionnalisées, comprenant un cœur et une enveloppe, caractérisées en ce que :7. Particulate reagent, having an affinity for biological compounds, comprising or consisting of organic and / or inorganic colloidal articulations, stable and functionalized, comprising a core and an envelope, characterized in that:
- le cœur est essentiellement solide, organique et/ou inorganique, et présente des groupements fonctionnels X choisis parmi les groupements amine, hydroxyle, thiol, aldéhyde, ester, anhydride, chlorure d'acide, carbonate, carbamate, isocyanate et isothiocyanate ou leurs mélanges, dont au moins une fraction a réagi avec d'autres groupements fonctionnels de l'enveloppe, etthe core is essentially solid, organic and / or inorganic, and has functional groups X chosen from amine, hydroxyl, thiol, aldehyde, ester, anhydride, acid chloride, carbonate, carbamate, isocyanate and isothiocyanate groups or mixtures thereof , at least a fraction of which reacted with other functional groups of the envelope, and
- l'enveloppe est constituée d'un polymère ionisable portant des groupements fonctionnels Z et Z', identiques ou différents, choisis parmi les groupements amine, acide carboxylique, ester, anhydride, aldéhyde, thiol, disulfure, α-halogénocarbonyle, acide sulfonique, isocyanate, et isothiocyanate, qui ont réagi partiellement avec les groupements fonctionnels X du cœur.the envelope consists of an ionizable polymer carrying functional groups Z and Z ′, which may be identical or different, chosen from the amine, carboxylic acid, ester, anhydride, aldehyde, thiol, disulfide, α-halocarbonyl, sulfonic acid groups, isocyanate, and isothiocyanate, which partially reacted with the functional groups X of the heart.
8. Réactif selon le revendication 7, caractérisé en ce que le cœur est organique et comprend au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N,N- dialkylacrylamide, tels que le N-isopropylacrylamide, le N-méthylacrylamide, le N-éthylméthacrylamide, le N-n-propylacrylamide, le N-n-propylméthacrylamide, le N-isopropylméthacrylamide, le N-cyclopropylacrylamide, le N,N- diéthylacrylamide, le N-méthyl-N-isopropylacrylamide, le N-méthyl-N-n- propylacrylamide ; les acrylates et les methacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, l'ethylstyrene, le tertio-butyl-styrène, le chlorométhylstyrène vinyltoluène ; leurs dérivés et les copolymères de ces monomères ente eux et/ou avec d'autres comonomères. 8. Reagent according to claim 7, characterized in that the core is organic and comprises at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from the monomers acrylamide and acrylate, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylamide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N -isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butyl-styrene, chloromethylstyrene vinyltoluene; their derivatives and the copolymers of these monomers ente them and / or with other comonomers.
9. Réactif selon la revendication 7, caractérisé en ce que le cœur est organique et inorganique et comprend au moins un polymère organique choisi parmi au moins un homopolymère ou un copolymère ou leurs mélanges, issu de la polymérisation d'au moins un monomère choisi parmi les monomères d'acrylamide et d'acrylate, en particulier les N-alkylacrylamide et N,N-dialkylacrylamide, tels que le N-isopropylacrylamide, le N- méthylacrylarnide, le N-éthylméthacrylamide, le N-n-propylacrylamide, le N-n- propylméthacrylamide, le N-isopropylméthacrylamide, le N- cyclopropylacrylamide, le N,N-diéthylacrylamide, le N-méthyl-N- isopropylacrylamide, le N-méthyl-N-n-propylacrylamide ; les acrylates et les methacrylates d'alkyle dans lesquels le groupement alkyle comprend de 3 à 20 atomes de carbone ; le styrène, le methylstyrene, l'ethylstyrene, le tertio-butyl- styrène, le chlorométhylstyrène vinyltoluène ; leurs dérivés et les copolymères de ces monomères ente eux et/ou avec d'autres comonomères ; et des particules inorganiques choisies parmi les particules d'oxydes métalliques, de fer, de titane, de cobalt, de zinc, de cuivre, de manganèse, de nickel ; la magnétite ; l'hématite, les ferrites, telles que les ferrites de manganèse, nickel, manganèse-zinc; les alliages de cobalt, nickel ; les zéolites ; le talc ; les argiles telles que bentonite et kaolin ; l'alumine ; la silice ; le graphite ; le noir de carbone ou autres matériaux inorganiques.9. Reagent according to claim 7, characterized in that the core is organic and inorganic and comprises at least one organic polymer chosen from at least one homopolymer or a copolymer or their mixtures, resulting from the polymerization of at least one monomer chosen from acrylamide and acrylate monomers, in particular N-alkylacrylamide and N, N-dialkylacrylamide, such as N-isopropylacrylamide, N-methylacrylarnide, N-ethylmethacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N, N-diethylacrylamide, N-methyl-N-isopropylacrylamide, N-methyl-Nn-propylacrylamide; alkyl acrylates and methacrylates in which the alkyl group comprises from 3 to 20 carbon atoms; styrene, methylstyrene, ethylstyrene, tert-butylstyrene, chloromethylstyrene vinyltoluene; their derivatives and the copolymers of these monomers ente them and / or with other comonomers; and inorganic particles chosen from particles of metal oxides, iron, titanium, cobalt, zinc, copper, manganese, nickel; magnetite; hematite, ferrites, such as manganese, nickel, manganese-zinc ferrites; cobalt, nickel alloys; zeolites; talc; clays such as bentonite and kaolin; alumina; silica; graphite; carbon black or other inorganic materials.
10. Réactif selon les revendications 7, 8 et 9, caractérisé en ce que le polymère de l'enveloppe est choisi parmi au moins un homopolymère ou copolymère hydrophile choisi parmi les homopolymères ou copolymères :10. Reagent according to Claims 7, 8 and 9, characterized in that the envelope polymer is chosen from at least one hydrophilic homopolymer or copolymer chosen from homopolymers or copolymers:
- issus de la polymérisation d'au moins un monomère choisi parmi les monomères dérivés de l'acrylamide ou de méthacrylamide ; l'acide acrylique, l'acide methacrylique ; les dérivés acrylates et methacrylates ; l'allylamine ; les dérivés styreniques ; à la condition s'il s'agit d'un homopolymère que celui ci comporte des groupements fonctionnels ionisables ; en particulier les copolymères ou homoplymères de l'anhydride maléique et les homopolymères ou copolymères de l'acryloxysuccinimide,- resulting from the polymerization of at least one monomer chosen from monomers derived from acrylamide or from methacrylamide; acrylic acid, methacrylic acid; acrylate and methacrylate derivatives; allylamine; styrenic derivatives; on the condition if it is a homopolymer that it contains ionizable functional groups; in particular the copolymers or homoplymers of maleic anhydride and the homopolymers or copolymers of acryloxysuccinimide,
- les polysaccharides, tels que le chitosane et le polyacide galacturonique,- polysaccharides, such as chitosan and poly galacturonic acid,
- les polypeptides, tels que la polylysine et la polyarginine,- polypeptides, such as polylysine and polyarginine,
- la polyéthylèneimine linéaire ou ramifiée, et - les dendrimères. - linear or branched polyethyleneimine, and - dendrimers.
11. Réactif selon la revendication 10, caractérisé en ce que le polymère d'enveloppe est le poly(anhydride maleique vinyl éther), le poly(N- vinylmorpholine-N-acryloxysuccinimide) ou le poly(N-vinylpyrrolidone-N- acryloxysuccinimide). 11. Reagent according to claim 10, characterized in that the envelope polymer is poly (vinyl ether maleic anhydride), poly (N-vinylmorpholine-N-acryloxysuccinimide) or poly (N-vinylpyrrolidone-N- acryloxysuccinimide) .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0000799A FR2804046B1 (en) | 2000-01-21 | 2000-01-21 | PROCESS FOR THE PREPARATION OF FUNCTIONALIZED STABLE COLLOIDAL PARTICLES AND PARTICLES OBTAINED |
FR00/00799 | 2000-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001052979A1 true WO2001052979A1 (en) | 2001-07-26 |
Family
ID=8846184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2001/000206 WO2001052979A1 (en) | 2000-01-21 | 2001-01-22 | Method for preparing stable and functionalised colloidal particles and resulting particulate reagent |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2804046B1 (en) |
WO (1) | WO2001052979A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1697543A2 (en) * | 2003-11-21 | 2006-09-06 | ANP Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
EP2100912A1 (en) * | 2008-03-07 | 2009-09-16 | Cognis IP Management GmbH | Use of polymers for modifying the surface tension of secure particles |
CN102736418A (en) * | 2004-10-26 | 2012-10-17 | Az电子材料美国公司 | Composition for coating over a photoresist pattern |
US8563329B2 (en) | 2005-05-02 | 2013-10-22 | Anp Technologies, Inc. | Polymer conjugate enhanced bioassays |
CN104368313A (en) * | 2014-10-25 | 2015-02-25 | 济南大学 | Preparation method and application of strontium ferrite-CMC (Carboxy Methylated Cellulose)-GO (Graphene Oxide) magnetic adsorbing agent for dye adsorption |
CN105080441A (en) * | 2015-07-28 | 2015-11-25 | 西北工业大学 | Preparation method of microcapsules coated with liquid alkene |
CN109261342A (en) * | 2018-08-02 | 2019-01-25 | 河南省核力科技发展有限公司 | A kind of preparation method of the coal separation dense media based on irradiation grafting |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4888124A (en) * | 1985-05-14 | 1989-12-19 | Basf Aktiengesellschaft | Preparation of stable dispersions of finely divided polyisocyanates and preparation of heat-crosslinkable isocyanate systems |
US5049469A (en) * | 1989-12-27 | 1991-09-17 | Eastman Kodak Company | Toner image pressure transfer method and toner useful therefor |
US5051469A (en) * | 1985-12-13 | 1991-09-24 | Monsanto Company | Rubber modified reaction molded nylon-6 block copolymers |
US5756273A (en) * | 1996-02-06 | 1998-05-26 | Eastman Kodak Company | Photographic element containing a core/shell polymer latex |
DE19803098A1 (en) * | 1998-01-28 | 1999-07-29 | Basf Ag | Particulate polymer, useful as impact modifier and/or dulling additive for thermoplastic molding materials |
-
2000
- 2000-01-21 FR FR0000799A patent/FR2804046B1/en not_active Expired - Fee Related
-
2001
- 2001-01-22 WO PCT/FR2001/000206 patent/WO2001052979A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4888124A (en) * | 1985-05-14 | 1989-12-19 | Basf Aktiengesellschaft | Preparation of stable dispersions of finely divided polyisocyanates and preparation of heat-crosslinkable isocyanate systems |
US5051469A (en) * | 1985-12-13 | 1991-09-24 | Monsanto Company | Rubber modified reaction molded nylon-6 block copolymers |
US5049469A (en) * | 1989-12-27 | 1991-09-17 | Eastman Kodak Company | Toner image pressure transfer method and toner useful therefor |
US5756273A (en) * | 1996-02-06 | 1998-05-26 | Eastman Kodak Company | Photographic element containing a core/shell polymer latex |
DE19803098A1 (en) * | 1998-01-28 | 1999-07-29 | Basf Ag | Particulate polymer, useful as impact modifier and/or dulling additive for thermoplastic molding materials |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8591904B2 (en) | 2003-11-21 | 2013-11-26 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US8501399B2 (en) | 2003-11-21 | 2013-08-06 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US8597653B2 (en) | 2003-11-21 | 2013-12-03 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
US7754500B2 (en) | 2003-11-21 | 2010-07-13 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
EP1697543A2 (en) * | 2003-11-21 | 2006-09-06 | ANP Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
EP2264191A1 (en) * | 2003-11-21 | 2010-12-22 | ANP Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
EP1697543A4 (en) * | 2003-11-21 | 2006-11-15 | Anp Technologies Inc | Asymmetrically branched polymer conjugates and microarray assays |
CN102736418A (en) * | 2004-10-26 | 2012-10-17 | Az电子材料美国公司 | Composition for coating over a photoresist pattern |
US8563329B2 (en) | 2005-05-02 | 2013-10-22 | Anp Technologies, Inc. | Polymer conjugate enhanced bioassays |
US9176142B2 (en) | 2005-05-02 | 2015-11-03 | Anp Technologies, Inc. | Polymer conjugate enhanced bioassays |
EP2100912A1 (en) * | 2008-03-07 | 2009-09-16 | Cognis IP Management GmbH | Use of polymers for modifying the surface tension of secure particles |
CN104368313A (en) * | 2014-10-25 | 2015-02-25 | 济南大学 | Preparation method and application of strontium ferrite-CMC (Carboxy Methylated Cellulose)-GO (Graphene Oxide) magnetic adsorbing agent for dye adsorption |
CN105080441A (en) * | 2015-07-28 | 2015-11-25 | 西北工业大学 | Preparation method of microcapsules coated with liquid alkene |
CN105080441B (en) * | 2015-07-28 | 2017-10-13 | 西北工业大学 | A kind of preparation method for coating liquid olefinic microcapsules |
CN109261342A (en) * | 2018-08-02 | 2019-01-25 | 河南省核力科技发展有限公司 | A kind of preparation method of the coal separation dense media based on irradiation grafting |
CN109261342B (en) * | 2018-08-02 | 2020-08-07 | 河南省核力科技发展有限公司 | Preparation method of dense medium for coal dressing based on irradiation grafting |
Also Published As
Publication number | Publication date |
---|---|
FR2804046B1 (en) | 2002-07-05 |
FR2804046A1 (en) | 2001-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1966260B1 (en) | Process for preparing composite particles, composite particles obtained, and their use in a diagnostic test | |
EP1226438B1 (en) | Composite nanospheres and their conjugates with biomolecules | |
EP1397429B1 (en) | Composite particles, derived conjugates, preparation method thereof and applications of same | |
US20220056184A1 (en) | Inverse ugelstad particles | |
US6573313B2 (en) | Amphiphilic core-shell latexes | |
Delair et al. | Amino-containing cationic latex–oligodeoxyribonucleotide conjugates: application to diagnostic test sensitivity enhancement | |
EP0777691B1 (en) | Polymerisation process for the preparation of calibrated monodisperse latex in dispersion | |
CA2157811A1 (en) | Biotinylated latex microsphere; process for preparing the same and use thereof as a biological detector | |
IE980447A1 (en) | Succinimide containing polymers and latices prepared from same | |
Herold et al. | Polymer nanoparticles with activated ester surface by using functional surfmers | |
WO2001052979A1 (en) | Method for preparing stable and functionalised colloidal particles and resulting particulate reagent | |
US20020160526A1 (en) | Process for isolating a target biological material, capture phase, detection phase and reagent | |
US20060134420A1 (en) | Nanometric or mesoscopic dissymetric particles, and method for preparing same | |
Musyanovych et al. | Grafting of amino functional monomer onto initiator-modified polystyrene particles | |
Guo et al. | Core/shell molecular imprinting microparticles prepared using RAFT technology for degradation of paraoxon | |
JP3215455B2 (en) | Polyoxyalkylene side chain containing copolymer | |
JPH059229A (en) | Succinimide-containing polymer and latex prepared therefrom | |
JPH028271B2 (en) | ||
US20230272127A1 (en) | Polymeric particles | |
Zobel et al. | Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methods | |
Govender et al. | Affinity chromatography using biocompatible and reusable biotinylated membranes | |
JP6066202B2 (en) | Magnetic particles | |
Men'shikova et al. | Synthesis of polymethyl methacrylate microspheres in the presence of dextran and its derivatives | |
CA1218185A (en) | Acrolein microspheres | |
Keller | Functional Core-Shell Nanoparticles for Enzyme Immobilization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |